(+)-schisandrin B multiple interactions ISO RGD:1307869 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SAT2 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1317312 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in increased expression of SAT2 mRNA CTD PMID:22079256 1-naphthyl isothiocyanate decreases expression ISO RGD:1307869 6480464 1-Naphthylisothiocyanate results in decreased expression of SAT2 mRNA CTD PMID:30723492 17alpha-ethynylestradiol decreases expression ISO RGD:1307869 6480464 Ethinyl Estradiol results in decreased expression of SAT2 mRNA CTD PMID:17557909 17beta-estradiol decreases expression ISO RGD:1317312 6480464 Estradiol results in decreased expression of SAT2 mRNA CTD PMID:23019147 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1307869 6480464 Tetrachlorodibenzodioxin results in decreased expression of SAT2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1307869 6480464 Tetrachlorodibenzodioxin results in increased expression of SAT2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1317312 6480464 Tetrachlorodibenzodioxin affects the expression of SAT2 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SAT2 mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression ISO RGD:1307869 6480464 2, 4-dinitrotoluene affects the expression of SAT2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO RGD:1307869 6480464 2, 6-dinitrotoluene affects the expression of SAT2 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1317312 6480464 Lactic Acid results in decreased expression of SAT2 mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1317312 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SAT2 mRNA CTD PMID:28628672 acetamide decreases expression ISO RGD:1307869 6480464 acetamide results in decreased expression of SAT2 mRNA CTD PMID:31881176 antirheumatic drug increases expression ISO RGD:1317312 6480464 Antirheumatic Agents results in increased expression of SAT2 mRNA CTD PMID:24449571 arsenous acid multiple interactions ISO RGD:1317312 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to SAT2 protein] CTD PMID:26598702 benzo[a]pyrene increases expression ISO RGD:1317312 6480464 Benzoapyrene results in increased expression of SAT2 mRNA CTD PMID:21632981 bisphenol A affects expression ISO RGD:1307869 6480464 bisphenol A affects the expression of SAT2 mRNA CTD PMID:25181051 bisphenol A affects expression ISO RGD:1317312 6480464 bisphenol A affects the expression of SAT2 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1317312 6480464 bisphenol A results in increased expression of SAT2 mRNA CTD PMID:29275510 bisphenol A increases methylation ISO RGD:1307869 6480464 bisphenol A results in increased methylation of SAT2 gene CTD PMID:28505145 bisphenol F multiple interactions ISO RGD:1317312 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SAT2 mRNA CTD PMID:28628672 buspirone increases expression ISO RGD:1307869 6480464 Buspirone results in increased expression of SAT2 mRNA CTD PMID:24136188 busulfan increases expression EXP 6480464 Busulfan results in increased expression of SAT2 mRNA, Busulfan results in increased expression of SAT2 protein CTD PMID:28578006 carbamazepine affects expression ISO RGD:1317312 6480464 Carbamazepine affects the expression of SAT2 mRNA CTD PMID:24752500 cerium trichloride increases expression EXP 6480464 cerous chloride results in increased expression of SAT2 mRNA CTD PMID:23573234 copper atom increases expression ISO RGD:1307869 6480464 Copper results in increased expression of SAT2 mRNA CTD PMID:30556269 copper(0) increases expression ISO RGD:1307869 6480464 Copper results in increased expression of SAT2 mRNA CTD PMID:30556269 crocidolite asbestos increases expression ISO RGD:1317312 6480464 Asbestos, Crocidolite results in increased expression of SAT2 mRNA CTD PMID:29523930 cyclosporin A increases expression ISO RGD:1317312 6480464 Cyclosporine results in increased expression of SAT2 mRNA CTD PMID:25562108 dexamethasone multiple interactions ISO RGD:1317312 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SAT2 mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions ISO RGD:1317312 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to SAT2 protein] CTD PMID:26598702 dibutyl phthalate decreases expression ISO RGD:1307869 6480464 Dibutyl Phthalate results in decreased expression of SAT2 mRNA CTD PMID:21266533 diclofenac affects expression ISO RGD:1317312 6480464 Diclofenac affects the expression of SAT2 mRNA CTD PMID:24752500 dorsomorphin multiple interactions ISO RGD:1317312 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1317312 6480464 Doxorubicin results in increased expression of SAT2 mRNA CTD PMID:29803840 endosulfan increases expression ISO RGD:1307869 6480464 Endosulfan results in increased expression of SAT2 mRNA CTD PMID:29391264 ethyl methanesulfonate increases expression ISO RGD:1317312 6480464 Ethyl Methanesulfonate results in increased expression of SAT2 mRNA CTD PMID:23649840 flutamide decreases expression ISO RGD:1307869 6480464 Flutamide results in decreased expression of SAT2 mRNA CTD PMID:24136188 formaldehyde increases expression ISO RGD:1317312 6480464 Formaldehyde results in increased expression of SAT2 mRNA CTD PMID:23649840 glafenine decreases expression ISO RGD:1307869 6480464 Glafenine results in decreased expression of SAT2 mRNA CTD PMID:24136188 hydrogen peroxide affects expression ISO RGD:1317312 6480464 Hydrogen Peroxide affects the expression of SAT2 mRNA CTD PMID:20044591 indometacin multiple interactions ISO RGD:1317312 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SAT2 mRNA CTD PMID:28628672 lead(0) affects splicing ISO RGD:1317312 6480464 Lead affects the splicing of SAT2 mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:1317312 6480464 Lead affects the splicing of SAT2 mRNA CTD PMID:28903495 leflunomide increases expression ISO RGD:1307869 6480464 leflunomide results in increased expression of SAT2 mRNA CTD PMID:24136188 methyl methanesulfonate increases expression ISO RGD:1317312 6480464 Methyl Methanesulfonate results in increased expression of SAT2 mRNA CTD PMID:23649840 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SAT2 mRNA CTD PMID:17562736 phenobarbital affects expression ISO RGD:1317312 6480464 Phenobarbital affects the expression of SAT2 mRNA CTD PMID:19159669 pirinixic acid multiple interactions ISO RGD:1317312 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SAT2 mRNA CTD PMID:19710929 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of SAT2 mRNA CTD PMID:20813756 , PMID:23811191 potassium chromate increases expression ISO RGD:1317312 6480464 potassium chromateVI results in increased expression of SAT2 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1317312 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in increased expression of SAT2 mRNA CTD PMID:22079256 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of SAT2 mRNA CTD PMID:27225895 pravastatin decreases expression ISO RGD:1307869 6480464 Pravastatin results in decreased expression of SAT2 mRNA CTD PMID:27225895 rac-lactic acid decreases expression ISO RGD:1317312 6480464 Lactic Acid results in decreased expression of SAT2 mRNA CTD PMID:30851411 rotenone increases expression ISO RGD:1307869 6480464 Rotenone results in increased expression of SAT2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1317312 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 sodium arsenite increases expression ISO RGD:1317312 6480464 sodium arsenite results in increased expression of SAT2 mRNA CTD PMID:22714537 sulindac increases activity EXP 6480464 Sulindac results in increased activity of SAT2 protein CTD PMID:17474863 sulindac increases expression EXP 6480464 Sulindac results in increased expression of SAT2 mRNA CTD PMID:17474863 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of SAT2 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:1307869 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SAT2 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:1307869 6480464 Carbon Tetrachloride results in decreased expression of SAT2 mRNA CTD PMID:31150632 thioacetamide decreases expression ISO RGD:1307869 6480464 Thioacetamide results in decreased expression of SAT2 mRNA CTD PMID:23411599 trichloroethene increases methylation ISO RGD:1307869 6480464 Trichloroethylene results in increased methylation of SAT2 gene CTD PMID:27618143 trichostatin A decreases expression ISO RGD:1317312 6480464 trichostatin A results in decreased expression of SAT2 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1317312 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of SAT2 mRNA CTD PMID:27188386 trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of SAT2 mRNA CTD PMID:19042947 valproic acid affects expression ISO RGD:1317312 6480464 Valproic Acid affects the expression of SAT2 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1317312 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of SAT2 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1317312 6480464 Valproic Acid results in decreased expression of SAT2 mRNA CTD PMID:23179753 more ... zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of SAT2 mRNA CTD PMID:27225895 zaragozic acid A increases expression ISO RGD:1307869 6480464 squalestatin 1 results in increased expression of SAT2 mRNA CTD PMID:27225895